Showing results (121-130 of 180) with videos related to

Sort By:
Pageof 18
Anticancer Research|December 7, 2016
Lung Cancer in Women with a Family History of Cancer: The Spanish Female-specific Database WORLD07Dolores Isla, Enriqueta Felip, Nuria Viñolas, et al.
Epigenetics|December 9, 2014
Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapyOlga Pernía, Cristobal Belda-Iniesta, Veronica Pulido, et al.
Cancers|April 1, 2020
A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy ResponseOlga Pernía, Ana Sastre-Perona, Carlos Rodriguez-Antolín, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2022
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancerAntonio José Conde-Moreno, Aránzazu González-Del-Alba, Fernando López-Campos, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|December 16, 2022
Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancerAurora Rodríguez Pérez, Enriqueta Felip Font, Rodolfo Chicas-Sett, et al.
British Journal of Clinical Pharmacology|January 31, 2018
The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinibKarthick Vishwanathan, Paul A Dickinson, Karen So, et al.
Histopathology|August 18, 2017
Aligning digital CD8+ scoring and targeted next-generation sequencing with programmed death ligand 1 expression: a pragmatic approach in early-stage squamous cell lung carcinomaEsther Conde, Alejandra Caminoa, Carolina Dominguez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 13, 2018
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and BiomarkersSolange Peters, Rolf Stahel, Lukas Bubendorf, et al.
The Lancet. Oncology|September 14, 2007
Expression of choline kinase alpha to predict outcome in patients with early-stage non-small-cell lung cancer: a retrospective studyAna Ramírez de Molina, Jacinto Sarmentero-Estrada, Cristóbal Belda-Iniesta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 9, 2024
ctDNA Dynamics and Mechanisms of Acquired Resistance in Patients Treated with Osimertinib with or without Bevacizumab from the Randomized Phase II ETOP-BOOSTER TrialRoss A Soo, Urania Dafni, Ji-Youn Han, et al.
Pageof 18